Apse's Debt Round

Apse raised a round of funding on June 01, 2017.

Apse is a biotechnology company seeking to commercialize a portfolio of Novel Nanomaterials useful for the manufacture of recombinant RNA and proteins and for Nanotechnology applications.…

Articles about Apse's Debt Round: